Responsible Use of Control-IQ Technology
Even with sophisticated systems like the t:slim X2 insulin pump that has Control-IQ technology, you’re still accountable for controlling your diabetes. Control-IQ technology cannot eliminate all low or high blood glucose levels. It is created to help decrease the variability of glucose however, it is dependent on an accurate and precise input of information like meals and times of exercise or sleep.
Control-IQ technology won’t work as designed when you do not use all components of the system, which includes your CGM as well as infusion sets, and pump cartridges in the manner advised. It is important to note that the system can’t modify your insulin dose in the event that the pump isn’t getting CGM readings. There are instances or emergencies which the system might not be able of recognizing or addressing, pay attention to the symptoms and follow the recommendations of your doctor.
* Dexcom CGM sold separately.
Plus, additional feature upgrades aren’t currently available for the t.slim the X2 insulin pump that has Control-IQ technology. Control-IQ technology is accessible only to customers within the United States or Canada, as well as other regions that are selected. Future updates for all or a few of Tandem’s offerings may not be made available and might not be available everywhere, and are subject to regulatory approvals as required by the applicable regulator.
Software updates are available only to customers in warranty when they update their pump. Training may be required for accessing forthcoming software update. Costs could apply. Tandem could end some features and software over time, at its own discretion.
* Tandem Diabetes Care has a settlement arrangement in place with Matt Vande Vegte.
The individual symptoms, conditions or circumstances and the results can differ. You should consult with your physician or a qualified health professional about your medical condition and treatment. Take a look at this Important Safety Information below before making use of an Tandem Diabetes Care product. Remove the infusion set from your body prior to flying in an airplane that does not have pressurization in the cabin or on aircrafts designed for aerobatics and combat simulation (pressurized as well or unpressurized).
Rapid shifts in altitude or gravity could affect insulin delivery and can cause injuries. For your safety, make sure you do not expose your Tandem pump at temperatures lower than 40 degF (5degC) or over 99degF (37degC) since insulin may freeze at low temperatures, or degrade when exposed to high temperatures.
1. dQ&A USA Diabetes Connections Surveys, 2013-2021.
Important Safety Information Tandem insulin Pump
RX ONLY. The t:slim X2 pump as well as Control-IQ technology are designed for use by one patient. The t:slim pump and Control-IQ technology is recommended to be used together with NovoLog and Humalog U-100 insulin. The insulin pump t:slim: The t:slim X2 insulin pump that has interoperable technology is an alternative controller-enabled (ACE) pump designed for subcutaneous delivery of insulin at fixed or variable amounts, to aid in the treatment of diabetes in patients who require insulin.
It is able to securely and reliably communicate with digitally connected, compatible devices, such as automatic insulin dose software to execute, receive commands, and then confirm them that are sent from such devices. The t:slim X2 pump has been intended for use by people who are six years old or more.
Control-IQ technology Control-IQ technology is designed to be used with a compatible Continuous Glucose Monitor (iCGM available separately) and the ACE pump that can automate the increase and decrease, or stop the delivery of basal insulin in accordance with iCGM readings and the predicted glucose levels. It also delivers correction boluses in the event that the glucose level is expected to be higher than an established threshold. Control-IQ technology is designed to assist in the treatment of Type 1 diabetes mellitus in people aged six and over.
Control-IQ technology is not to be used by any person younger than the age of six. Also, it should not be used by those who need less than 10 insulin units daily or weigh less than 55 lbs.
Control-IQ technology should not be used for use by pregnant women, patients taking dialysis, or infirm patients. Use Control-IQ technology only in conjunction with hydroxyurea. Customers of the slim pump and Control-IQ technology should utilize your insulin pump CGM along with all components of the system in accordance to their specific instructions for their use.
Test blood glucose levels according to the guidelines suggested by their health care provider be able to demonstrate appropriate skills in counting carbs Maintain sufficient self-care for diabetes capabilities;
visit your health care provider(s) regularly and have sufficient hearing and vision to comprehend the features of the pump which includes alarms, alerts, and reminders. The t:slim X2 pump as well as the CGM sensor and transmitter must be removed prior to MRI, CT, or diathermy treatment. Visit tandemdiabetes.com/safetyinfo for additional important safety information.